Ferrous citrate, fe-59 - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ferrous citrate, fe-59 and what is the scope of freedom to operate?
Ferrous citrate, fe-59
is the generic ingredient in one branded drug marketed by Mallinckrodt and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for ferrous citrate, fe-59
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 3 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ferrous citrate, fe-59 at DailyMed |
Recent Clinical Trials for ferrous citrate, fe-59
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Neopharma Japan Co., Ltd. | Phase 2 |
Parexel | Phase 2 |
University of Alabama at Birmingham | N/A |
US Patents and Regulatory Information for ferrous citrate, fe-59
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mallinckrodt | FERROUS CITRATE FE 59 | ferrous citrate, fe-59 | INJECTABLE;INJECTION | 016729-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |